Clinician's Roundtable

ReachMD
undefined
Oct 12, 2007 • 13min

Palliative Care & the Special Care Newborn

Host: Susan Dolan, RN, JD Guest: Brian Carter, MD Join Dr. Brian Carter, Professor of Pediatrics in the Division of Neonatology at Vanderbilt Children's Hospital in Nashville, Tennessee, to discuss palliative care and hospice for the special care newborn.
undefined
Oct 12, 2007 • 13min

The Special Care Newborn

Host: Susan Dolan, RN, JD Guest: Brian Carter, MD Dr. Brian Carter, professor of pediatrics in the division of neonatology at Vanderbilt's Children's Hospital in Nashville, Tennessee, discusses the special care newborn with host Susan Dolan.
undefined
Oct 12, 2007 • 13min

Type1 Diabetes Cure Research & Autoimmune Diseases

Host: Bruce Bloom, DDS, JD Guest: Denise L. Faustman, MD Dr. Denise L. Faustman, Associate Professor of Medicine at Harvard Medical School and Director of the Immunobiology Laboratories at the Massachusetts General Hospital discusses how her Type 1 diabetes cure research may be applicable to other autoimmune diseases such as lupus.
undefined
Oct 12, 2007 • 13min

Type 1 Diabetes: Control and Cure

Host: Bruce Bloom, DDS, JD Guest: Denise L. Faustman, MD Type 1 diabetes affects over 1 million Americans and costs billions of dollars every year. Dr. Denise L. Faustman, director of the Immunobiology Laboratories at the Massachusetts General Hospital in Boston, discusses with host Dr. Bruce Bloom her cure research and the possibility of a generic drug cure.
undefined
Oct 11, 2007 • 13min

Congress's Efforts To Fight Diabetes

Host: Mark Nolan Hill, MD Guest: Mark Kirk, JD Congressman Mark Kirk, vice chair of the congressional diabetes caucus speaks with host Dr. Mark Nolan Hill both about stem cell research and the challenging problem of solving the diabetes epidemic.
undefined
Oct 11, 2007 • 13min

The Macrogenics of Diabetes

Host: Danny Petrasek, MD, PhD Guest: Ronald Wilder, MD, PhD How has Type 1 diabetes evolved in our society? When does the disease strike, and can we take preemptive action before it does? Dr. Ron Wilder, an internationally recognized rheumatologist and immunologist, speaks with host Dr. Danny Petrasek, addressing our ability to interfere with the disease physiology.
undefined
Oct 11, 2007 • 13min

Novel Therapies for Type 1 Diabetes

Host: Danny Petrasek, MD, PhD Guest: Ronald Wilder, MD, PhD How has Type 1 diabetes evolved in our society? When does the disease strike, and can we take preemptive action before it does? Dr. Ron Wilder, an internationally recognized rheumatologist and immunologist, speaks with host Dr. Danny Petrasek, addressing our ability to interfere with the disease physiology.
undefined
Oct 11, 2007 • 13min

Congress and Healthcare for Veterans

Host: Mark Nolan Hill, MD Guest: Mark Kirk, JD As a veteran himself and a congressman, Mark Kirk works tirelessly to improve and expand healthcare resources for our veterans. What new healthcare initiatives are underway to serve the needs of the Unites States veterans?
undefined
Oct 11, 2007 • 13min

Healthcare Policy: Malpractice & Social Medicine

Host: Mark Nolan Hill, MD Guest: Mark Kirk, JD In this segment Congressman Mark Kirk speaks to host Dr. Mark Nolan Hill about medical malpractice as a contributor to the high costs of healthcare. They then go on to discuss the idea of a Government Controlled Health Plan and why this would not be an ideal solution to US healthcare reform.
undefined
Oct 11, 2007 • 13min

Shift in Thinking About Hormone Replacement

Host: Larry Kaskel, MD Guest: Howard Hodis, MD What is the latest thinking about hormone replacement therapy? Join Dr. Larry Kaskel in an interview with Dr. Howard Hodis about some recent studies about ERT and cardiovascular health.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app